Breast Cancer (Screening)

Technology Patent Announced for Early Cancer Detection

Published in Women's Health Weekly, December 23rd, 1996

Oncor, Inc., Gaithersburg, Maryland, announced that a patent has been issued covering methods incorporating p43 for the detection of breast cancer.

The patented technology measures the amount of an isoform of ferritin (p43) bound to lymphocytes. Work published by Dr. Chaya Moroz, Tel Aviv University Sackler School of Medicine, Tel Aviv, Israel, and others, has demonstrated that the p43 protein is elevated at an early stage in breast cancer.

"This patent paves the way for Oncor to develop a blood test for early (stage IIH) breast cancer, as well as in situ (localized) cancer, which may provide the opportunity to detect and treat breast cancer at an...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly

Source: Women's Health Weekly (1996-12-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry